Associate Professor, Medicine, University of Alabama School of Medicine

Oncology

James A. Posey III, MD practices Oncology. He researched medicine at Howard University College of Medicine. He received awards:"Meaningful Use Stage 1 Certification". Doctor James A. Posey III, MD is also a published MD. He has 31 publication published. The most recent publication is: Genetic factors for the development of Alzheimer disease in the Cherokee Indian.

Publications

---

• Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone.
• Erratum to: Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging.
• The effects of Liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor recep...
• Gastric Cancer, Version 2.2013.
• Genetic factors for the development of Alzheimer Disease in the Cherokee Indian.
• Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic coloRectal cancer.
• Phase II and pharmacokinetic trial of rebeccamycin Analog in advanced biliary cancers.
• A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies.
• Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal Cancer: a...
• Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon Cancer.
• A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic Cancer.
• Activity of sunitinib in patients with advanced neuroendocrine Tumors.
• Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon Cancer.
• NCCN Practice Guidelines for ColoRectal Cancer.
• Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5).
• A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advance...
• Evaluation of lymph node numbers for adequate staging of Stage II and III colon Cancer.
• Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies.
• A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from coloRectal carcinoma.
• A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid Tumors.
• Hepatobiliary Cancers. Clinical practice guidelines in oncology.
• Gastric Cancer Clinical Practice Guidelines.
• Esophageal Cancer Clinical Practice Guidelines.
• Esophageal and esophagogastric junction Cancers.
• Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine Tumors after failure of cytotoxic chemotherapy: a phase II trial.
• NCCN clinical practice guidelines in oncology: hepatobiliary Cancers.
• Gastric Cancer.
• Resectability of pancreatic adenocarcinoma in patients with locally advanced Disease downstaged by preoperative therapy: a challenge for MDCT.
• Multidetector computed tomography during combined therapy for Pancreatic adenocarcinoma.
• Phase 1 study of weekly polyethylene glycol-camptothecin in patients with advanced solid tumors and Lymphomas.

Schools

---

• Howard University College Of Medicine

• Georgetown University Med Center

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Anal and Rectal Cancer
• Anemia
• Bile Duct Cancer
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

• Aetna
• Blue Card PPO
• Dental Blue 100/200/300
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• Commercial Insurance Company
• Coventry Health Care
• First Health (Coventry Health Care) PPO
• Choice Care PPO
• Medicare MCR
• MultiPlan PPO
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• United Healthcare

Awards

---

• Meaningful Use Stage 1 Certification

Education

---

• Georgetown University Hospital
• Howard University College of Medicine

Hospital

---

• University of Alabama Hospital
• Children's of Alabama

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Tina E. Wood, MD This Doctor is OpenDoctor Recommended.
	Dr. John G. Hankins, MD This Doctor is OpenDoctor Recommended.
	Dr. Lisle M. Nabell, MD This Doctor is OpenDoctor Recommended.
	Dr. Frank A. Bailey, MD This Doctor is OpenDoctor Recommended.
	Dr. Ira Gore, MD This Doctor is OpenDoctor Recommended.
	Dr. Mollie R. Deshazo, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert M. Crescentini II, MD This Doctor is OpenDoctor Recommended.
	Dr. Swetha Yadav, MD This Doctor is OpenDoctor Recommended.
	Dr. Graeme B. Bolger, MD This Doctor is OpenDoctor Recommended.
	Dr. Andres Forero-Torres, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog